December 4, 2023 Experience Tencent $100 million strategic investment in Global Blue Group Holding We advised Tencent on the transaction
November 22, 2023 Experience Smith+Nephew acquisition of CartiHeal We are advising Smith+Nephew on the acquisition
November 10, 2023 Experience Sibanye-Stillwater $211.5 million acquisition of Reldan We are advising Sibanye-Stillwater on the acquisition
November 6, 2023 Experience Williams acquisitions of Cureton and Rocky Mountain Midstream We are advising Williams on the acquisitions
November 1, 2023 Experience Forbion European Acquisition $138 million combination with enGene We advised Forbion European Acquisition on its de-SPAC transaction
October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
October 23, 2023 Experience Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant We are advising Roche on the acquisition
October 18, 2023 Experience Ferrara Candy acquisition of Jelly Belly Candy We are advising Ferrara on the acquisition
October 10, 2023 Experience Instant Brands sale of substantially all of its assets to Centre Lane Partners We are advising Instant Brands on the sale